Literature DB >> 11939937

Progress of visual dysfunction in Parkinson's disease.

T Müller1, D Woitalla, S Peters, K Kohla, H Przuntek.   

Abstract

Studies on progression of Parkinson's disease (PD) mainly focus on the nigrostriatal dopaminergic decline, but not on the visual system. We determined progression of (i) disturbed color vision, assessed with the Farnsworth-Munsell 100 Hue test (FMT) and (ii) intensity of PD in 18 patients. Significant differences occurred between (i) initial FMT error scores and follow-up results 3 years later (P=0.002) and analogously (ii) scored intensity of PD (P=0.002). A relation between computed differences of FMT error scores and rated activities of daily living appeared. Deterioration of color vision progresses in PD.

Entities:  

Mesh:

Year:  2002        PMID: 11939937     DOI: 10.1034/j.1600-0404.2002.1o154.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG.

Authors:  Anja M Palmowski-Wolfe; Maria Timoner Perez; Stefanie Behnke; Gerhard Fuss; Martin Martziniak; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2006-06-22       Impact factor: 2.379

2.  Depth perception in cerebellar and basal ganglia disease.

Authors:  Matthias Maschke; Christopher M Gomez; Paul J Tuite; Kristen Pickett; Jürgen Konczak
Journal:  Exp Brain Res       Date:  2006-05-30       Impact factor: 1.972

3.  Color vision deficiency in a middle-aged population: the Shahroud Eye Study.

Authors:  Ebrahim Jafarzadehpur; Hassan Hashemi; Mohammad Hassan Emamian; Mehdi Khabazkhoob; Shiva Mehravaran; Mohammad Shariati; Akbar Fotouhi
Journal:  Int Ophthalmol       Date:  2014-02-14       Impact factor: 2.031

Review 4.  Dopamine and aging: intersecting facets.

Authors:  C David Rollo
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

5.  Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire.

Authors:  Carlijn D J M Borm; Femke Visser; Mario Werkmann; Debbie de Graaf; Diana Putz; Klaus Seppi; Werner Poewe; Annemarie M M Vlaar; Carel Hoyng; Bastiaan R Bloem; Thomas Theelen; Nienke M de Vries
Journal:  Neurology       Date:  2020-03-11       Impact factor: 9.910

Review 6.  Visual dysfunction in Parkinson's disease.

Authors:  Rimona S Weil; Anette E Schrag; Jason D Warren; Sebastian J Crutch; Andrew J Lees; Huw R Morris
Journal:  Brain       Date:  2016-11-01       Impact factor: 15.255

7.  Use of a Modified STROOP Test to Assess Color Discrimination Deficit in Parkinson's Disease.

Authors:  Rebekah G Langston; Tuhin Virmani
Journal:  Front Neurol       Date:  2018-09-12       Impact factor: 4.003

Review 8.  Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.

Authors:  Alessia Indrieri; Rocco Pizzarelli; Brunella Franco; Elvira De Leonibus
Journal:  Front Neurosci       Date:  2020-10-19       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.